Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An anaplastic astrocytoma (grade III astrocytic tumor) or glioblastoma (grade IV astrocytic tumor).
Biomarker and diagnostic research for high grade astrocytic tumor has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include procedural interventions and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
5 publications have been identified in PubMed for high grade astrocytic tumor. Research spans Basic Science / Preclinical (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Henriksen OM (2024). [PMID: 39659835](https://pubmed.ncbi.nlm.nih.gov/39659835/). *Neurooncol Adv*. [Diagnostic / Biomarker]
Hainfellner A (2024). [PMID: 39192069](https://pubmed.ncbi.nlm.nih.gov/39192069/). *J Neurooncol*. [Epidemiology / Natural History]
Alarfaj A (2024). [PMID: 38974570](https://pubmed.ncbi.nlm.nih.gov/38974570/). *Surg Neurol Int*. [Case Report / Case Series]
Molín J (2024). [PMID: 39061577](https://pubmed.ncbi.nlm.nih.gov/39061577/). *Animals (Basel)*. [Basic Science / Preclinical]
Staszkiewicz R (2024). [PMID: 39001398](https://pubmed.ncbi.nlm.nih.gov/39001398/). *Cancers (Basel)*. [Basic Science / Preclinical]
Data assembled from 4 of 12 sources · Last updated Oct 4, 2026, 3:02 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center